Expanded Access for Bromodomain and Extra-Terminal (BET) Inhibitor

Bristol-Myers Squibb (BMS)

Status

Treatments: Drug: BET Inhibitor

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT05301972

CA011-011

Details and patient eligibility

About

This is an expanded access designed to provide access to Bromodomain and Extra-Terminal (BET) Inhibitor for eligible participants.

Sex

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria